Physician profile
Lauren C Ade
NPI 1598305070
$4,754.68
in general payments reported to CMS, 2019-2025
30 companies · $1,171 in 2025
The $1,171 reported for 2025 was more than what 91% of Clinical Nurse Specialist providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $259 · 2022: $678 · 2023: $1,178 · 2024: $1,469 · 2025: $1,171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,818.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,817.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,296.66 | 2021-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $870.94 | 2021-2025 | Lifevest |
| Pfizer INC. | $387.68 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $360.35 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $258.51 | 2021-2024 | Xarelto |
| Boston Scientific Corporation | $183.75 | 2023-2025 | Bodyguardian, Watchman Flx |
| E.R. Squibb & Sons, L.L.C. | $177.16 | 2023-2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $154.27 | 2022-2025 | Jardiance |
| Inspire Medical Systems, INC. | $149.96 | 2024-2025 | Inspire |
| Atricure, INC. | $148.49 | 2024 | |
| Kiniksa Pharmaceuticals, Ltd. | $103.87 | 2023 | Arcalyst |
| Kiniksa Pharmaceuticals International, Plc | $85.87 | 2024 | Arcalyst |
| Sanofi-Aventis U.S. LLC | $81.23 | 2024 | |
| Baxter Healthcare | $53.99 | 2023-2024 | Hillrom - Carnation Ambulatory Monitor |
| Astrazeneca Pharmaceuticals Lp | $53.29 | 2022-2024 | Farxiga |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $43.03 | 2025 | |
| Amarin Pharma, INC. | $39.21 | 2022 | |
| Alnylam Pharmaceuticals INC. | $38.31 | 2022-2025 | Amvuttra |
| Heartflow, INC. | $37.53 | 2024-2025 | |
| Impulse Dynamics (USA) INC. | $34.16 | 2024 | Optimizer |
| Regeneron Healthcare Solutions, INC. | $28.64 | 2023 | Evkeeza |
| Cvrx, INC. | $27.94 | 2024 | Barostim Neo System |
| Novo Nordisk INC | $24.38 | 2025 | Ozempic |
| Philips North America LLC | $23.30 | 2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Vital Connect, INC | $20.38 | 2024 | Vitalpatch Rtm |
| Medtronic, INC. | $19.45 | 2025 | Symplicity G3 |
| Edwards Lifesciences Corporation | $16.55 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.78 | 2023 | |
| Irhythm Technologies, INC. | $12.90 | 2022 | |
| Rigel Pharmaceuticals, INC. | $8.10 | 2023 | Rezlidhia, Tavalisse |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Ade listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.